Awareness of pharmacist interns regarding the side effects of new sugar lowering drugs (part 2)

Abstract

Type II diabetes mellitus (DM) is one of the most common endocrine diseases, so the issue of pharmacists'
awareness about side effects of hypoglycemic agents, rational and irrational combinations is an integral part
of effective pharmaceutical care.
The aim of the study – to assess the awareness of pharmacist interns regarding adverse reactions of new
hypoglycemic agents.
A questionnaire was developed and an anonymous voluntary remote survey of 74 pharmacist interns of
the specialty «226 Pharmacy, industrial pharmacy» was conducted.
As a result of the processing of the questionnaires of pharmacist interns regarding adverse reactions of
new hypoglycemic agents, it was shown that there was insufficient knowledge on the compositions of
combined hypoglycemic agents and satisfactory knowledge on the side effects of this group of drugs. The
need to provide special information on the features of diet therapy for different variants of the course of
diabetes, as well as on the problem of primary and secondary resistance to sulfonylurea derivatives, new
combination drugs, based on basal insulin and glucagon-like peptide-1 analogues, as well as rational and
irrational combinations of hypoglycemic agents was identified.
78% of respondents assessed their knowledge on the safety of hypoglycemic agents as those that require
improvement.
The results of the survey indicate the need to emphasize the pharmacosafety of drugs, including
hypoglycemic agents, when teaching the educational component «Clinical pharmacology».
The results of the study can be used to optimize the teaching of the disciplines «Clinical pharmacy and pharmaceutical care», «Clinical pharmacology», «Side effects of drugs» and internship training in the
specialty «Pharmacy».